Invention Grant
- Patent Title: Compositions and methods comprising the use of cell surface displayed homing endonucleases
-
Application No.: US12295201Application Date: 2007-03-27
-
Publication No.: US10407672B2Publication Date: 2019-09-10
- Inventor: Andrew M. Scharenberg
- Applicant: Andrew M. Scharenberg
- Applicant Address: US WA Seattle
- Assignee: Seattle Children's Hospital
- Current Assignee: Seattle Children's Hospital
- Current Assignee Address: US WA Seattle
- Agency: Cooley LLP
- International Application: PCT/US2007/007637 WO 20070327
- International Announcement: WO2007/123636 WO 20071101
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/10

Abstract:
According to particular exemplary aspects, DNA target site binding and cleavage properties of native, variant or modified homing endonucleases (HE) (e.g., LAGLIDAG (LHE), HNH, His-Cys Box, GIY-YIG, I-SspI-type, and fusions, muteins or variants thereof) in solution are recapitulated on the cell surface (e.g., as assessed by flow cytometric analysis) to provide for novel cells expressing one or more cell surface HEs (e.g., expressing one or more HE binding and/or cleavage specificities), novel cell libraries, and high-throughput methods for assessing target site binding, target site cleavage. The rapid analysis of HE and LHE-DNA interactions on the cell surface with concurrent sorting options provides for high-throughput library screening affording rapid identification, analysis and isolation of novel HEs or LHEs having novel sequence specificities. Such novel sequence specificities, obtained by said methods provide novel methods for introducing targeted DNA-strand cleavage events, and novel chromatin immunoprecipitation methods (CHIP methods).
Public/Granted literature
- US20090162937A1 COMPOSITIONS AND METHODS COMPRISING THE USE OF CELL SURFACE DISPLAYED HOMING ENDONUCLEASES Public/Granted day:2009-06-25
Information query